Skip to main content

ARYX Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Aryx Therapeutics Inc News

5 Drug Stock Losers of 2010

Clinical trial failures, poor sales and crushing debt pummeled shares of Vermillion, Oxigene and Angiotech in 2010.

Biotech Sector Weekly Rewind

Adam Feuerstein's take on the biotech sector's hits and misses during the week ended Nov. 5, 2010.

Biotech Sector Weekly Rewind

Adam Feuerstein's take on the biotech sector's hits and misses during the week ended Oct 22, 2010.

The Essential Biotech Sector Fall Preview

A biotech back-to-school guide with everything investors need to prepare for a busy fall season.

Biotech Stock Mailbag: BioSante Pharma

Biotech watchdog Adam Feuerstein addresses readers' questions about BioSante and other healthcare stocks.

Breaking News

Stock Market Today - 6/29: Stocks End Mixed As Recession Concerns Mount

Stocks ended mixed Wednesday as growth bets gave way to recession fears.

Should I Buy a House Now? (It's Personal and Complicated)

Mortgage rates are up and some markets have cooled down, but the reality is that the decision is very personal.

Crypto Crash Exposes Robinhood and Coinbase To Predators

A year can be a lifetime in the cryptocurrency world as major players are reeling from heavy losses.

Micron Earnings Preview: Will Critical Support Hold?

Micron is set to report earnings on Thursday after the close, but the stock sits on critical support. Will it hold or will it fold?